NDC properties for "0.8 ML Cyltezo 50 MG/ML Prefilled Syringe" (RxCUI 2640889)
About this data
The tables show NDC propoerties for 0.8 ML Cyltezo 50 MG/ML Prefilled Syringe with the RxCUI 2640889
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Cyltezo 50 MG/ML Prefilled Syringe (RxCUI 2640889)
BLA | BLA761058 |
---|---|
MMSL_CODE | BD32554 |
RxCUI | 2640889 |
SPL_SET_ID | 115ea79b-7209-7f19-b35d-36ec0828fbf5 |
Prescribable Synonym | CYLTEZO 40 MG in 0.8 ML Prefilled Syringe |
RXNAV_STR | 0.8 ML Cyltezo 50 MG/ML Prefilled Syringe |
RxNorm Name | 0.8 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] |
RxNorm Synonym | 0.8 ML Cyltezo 50 MG/ML Prefilled Syringe |
RxNorm Synonym | Cyltezo 40 MG per 0.8 ML Prefilled Syringe |
Related queries | Interactions (for RxCUI 2640889) |
NDC Properties
NDC Item 00597037045
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-45 |
NDC Item | 00597037045 |
Packaging | 1 KIT in 1 CARTON (0597-0370-45) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037072
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-72 |
NDC Item | 00597037072 |
Packaging | 1 KIT in 1 CARTON (0597-0370-72) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037082
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-82 |
NDC Item | 00597037082 |
Packaging | 2 KIT in 1 CARTON (0597-0370-82) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037045
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-45 |
NDC Item | 00597037045 |
Packaging | 1 KIT in 1 CARTON (0597-0370-45) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037072
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-72 |
NDC Item | 00597037072 |
Packaging | 1 KIT in 1 CARTON (0597-0370-72) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037082
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-82 |
NDC Item | 00597037082 |
Packaging | 2 KIT in 1 CARTON (0597-0370-82) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037045
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-45 |
NDC Item | 00597037045 |
Packaging | 1 KIT in 1 CARTON (0597-0370-45) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037072
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-72 |
NDC Item | 00597037072 |
Packaging | 1 KIT in 1 CARTON (0597-0370-72) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |
NDC Item 00597037082
NDC 9 | 0597-0370 |
---|---|
NDC 10 | 0597-0370-82 |
NDC Item | 00597037082 |
Packaging | 2 KIT in 1 CARTON (0597-0370-82) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784444 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0597-0370 |